| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 22.898 | 99.947 | 153.872 | 108.771 | 98.944 | 147.986 |
| Total Income - EUR | - | - | - | - | 22.898 | 99.975 | 153.907 | 109.039 | 99.233 | 147.989 |
| Total Expenses - EUR | - | - | - | - | 7.503 | 27.739 | 30.985 | 34.354 | 42.279 | 54.575 |
| Gross Profit/Loss - EUR | - | - | - | - | 15.395 | 72.236 | 122.922 | 74.685 | 56.954 | 93.414 |
| Net Profit/Loss - EUR | - | - | - | - | 15.166 | 71.256 | 121.383 | 73.617 | 55.984 | 89.551 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Sanopsy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 356 | 129 | 0 | 774 | 1.411 |
| Current Assets | - | - | - | - | 16.558 | 72.212 | 121.636 | 75.668 | 61.316 | 95.614 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 5.408 | 0 | 12.337 | 63.297 | 6.017 | 52.942 |
| Cash | - | - | - | - | 11.150 | 72.212 | 109.299 | 12.371 | 55.299 | 42.672 |
| Shareholders Funds | - | - | - | - | 15.208 | 71.299 | 119.580 | 73.657 | 55.870 | 89.592 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.373 | 1.301 | 2.270 | 2.033 | 6.294 | 7.627 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sanopsy S.r.l.